Home > Healthcare > Biopharmaceutical Fermentation Systems Market > Table of Contents

Biopharmaceutical Fermentation Systems Market – Product Type (Upstream [Bioreactor, Bioprocess Analyzer], Downstream [Chromatography, Filtration]), Application (Recombinant Proteins, Antibiotics, Probiotics), End User – Global Forecast (2024 – 2032)

  • Report ID: GMI9589
  • Published Date: May 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1   Market scope & definitions

1.2   Research design

1.2.1   Research approach

1.2.2   Data collection methods

1.3   Base estimates & calculations

1.3.1   Base year calculation

1.3.2   Key trends for market estimation

1.4   Forecast model

1.5   Primary research and validation

1.5.1   Primary sources

1.5.2   Data mining sources

Chapter 2   Executive Summary

2.1   Industry 3600 synopsis

Chapter 3   Industry Insights

3.1   Industry ecosystem analysis

3.2   Industry impact forces

3.2.1   Growth drivers

3.2.1.1    Growing demand for biopharmaceuticals

3.2.1.2    Growing investments for developing new biopharmaceuticals and biosimilars

3.2.1.3    Increasing regulatory approvals for biopharmaceutical products

3.2.1.4    Growing adoption of single use fermenters

3.2.2   Industry pitfalls & challenges

3.2.2.1    Requirements for high initial capital investments

3.2.2.2    Issues related to extractables and leachable

3.3   Growth potential analysis

3.4   Regulatory landscape

3.5   Future market trends

3.6   Gap analysis

3.7   Porter's analysis

3.8   PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1   Introduction

4.2   Company market share analysis

4.3   Company matrix analysis

4.4   Competitive positioning matrix

4.5   Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)

5.1   Key trends

5.2   Upstream products

5.2.1   Bioreactors/fermenters

5.2.2   Bioprocess analyzers

5.2.3   Process monitoring systems

5.2.4   Other upstream products

5.3   Downstream products

5.3.1   Filtration & separation

5.3.2   Chromatography

5.3.3   Consumables & accessories

5.3.4   Other downstream products

Chapter 6   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

6.1   Key trends

6.2   Recombinant proteins

6.3   Antibiotics

6.4   Probiotics

6.5   Other applications

Chapter 7   Market Estimates and Forecast, By End User, 2021 – 2032 ($ Mn)

7.1   Key trends

7.2   Biopharmaceutical companies

7.3   Contract research organizations

7.4   Academic research institutes

7.5   Other end users

Chapter 8   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

8.1   Key trends

8.2   North America

8.2.1   U.S.

8.2.2   Canada

8.3   Europe

8.3.1   Germany

8.3.2   UK

8.3.3   France

8.3.4   Spain

8.3.5   Italy

8.3.6   Netherlands

8.3.7   Rest of Europe

8.4   Asia Pacific

8.4.1   China

8.4.2   Japan

8.4.3   India

8.4.4   Australia

8.4.5   South Korea

8.4.6   Rest of Asia Pacific

8.5   Latin America

8.5.1   Brazil

8.5.2   Mexico

8.5.3   Rest of Latin America

8.6   Middle East and Africa

8.6.1   South Africa

8.6.2   Saudi Arabia

8.6.3   UAE

8.6.4   Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    Agilent Technologies, Inc.

9.2    Becton, Dickinson and Company

9.3    Bioengineering AG

9.4    Cellexus Limited

9.5    Danaher Corporation

9.6    Eppendorf AG

9.7    F. Hoffmann-La Roche Ltd.

9.8    GE HealthCare Technologies, Inc.

9.9    Getinge Group

9.10    Lonza Group AG

9.11    Merck KGaA

9.12    Nova Biomedicals

9.13    Sartorius Stedim Biotech

9.14    Thermo Fisher Scientific Inc.

9.15    ZETA

  

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 214
  • Countries covered: 22
  • Pages: 123
 Download Free Sample